ChartX
운영 · 3.4K 월 방문
ChartX는 노인 요양 시설을 위해 설계된 차세대 AI 기반 인프라입니다. 청구, 환자 등록 및 재무 관리를 자동화하여 운영을 간소화합니다. 이 플랫폼은 HIPAA를 준수하여 데이터 보안을 보장하며, 시설이 환자 치료를 향상시키고, 관리 오버헤드를 줄이며, 수익 주기 관리를 개선하도록 돕습니다.
VS
Weave
CRM · 1.3M 월 방문
Weave는 주로 의료 분야의 소규모 비즈니스를 위한 AI 기반 올인원 커뮤니케이션 및 성장 플랫폼입니다. VoIP 전화 시스템, 양방향 문자 메시지, 결제 처리 및 환자 참여 도구를 단일 통합 인터페이스에 통합합니다. AI를 활용하여 Weave는 병원이 운영을 간소화하고 환자 경험을 향상시키며 비즈니스 성장을 가속화하도록 돕습니다.
제품 개요
ChartX 제품 개요
ChartX는 노인 요양 시설을 위해 설계된 차세대 AI 기반 인프라입니다. 청구, 환자 등록 및 재무 관리를 자동화하여 운영을 간소화합니다. 이 플랫폼은 HIPAA를 준수하여 데이터 보안을 보장하며, 시설이 환자 치료를 향상시키고, 관리 오버헤드를 줄이며, 수익 주기 관리를 개선하도록 돕습니다.
Preview
Weave 제품 개요
Weave는 주로 의료 분야의 소규모 비즈니스를 위한 AI 기반 올인원 커뮤니케이션 및 성장 플랫폼입니다. VoIP 전화 시스템, 양방향 문자 메시지, 결제 처리 및 환자 참여 도구를 단일 통합 인터페이스에 통합합니다. AI를 활용하여 Weave는 병원이 운영을 간소화하고 환자 경험을 향상시키며 비즈니스 성장을 가속화하도록 돕습니다.
Preview
Detailed feature comparison
| Feature | ChartX | Weave |
|---|---|---|
| 주요 카테고리 | 운영 | CRM |
| 등록일 | 2025-08-11 | 2025-08-12 |
| 가격 | 유료 | 유료 |
| 공식 사이트 | www.chartx.ai | www.getweave.com |
| 제품 유형 | 웹사이트 | 웹사이트 |
| Performance data | ||
| 사용자 평점 | 확인되지 않음 | 확인되지 않음 |
| 댓글 | 0 | 0 |
| 월 방문 | 3.4K | 1.3M |
| 월 성장률 | 확인되지 않음 | 10.4% |
| 즐겨찾기 | 106 | 120 |
| Details | 상세 보기 | 상세 보기 |
ChartX vs Weave monthly traffic
Compare ChartX and Weave by monthly reach, traffic trend, visit depth, top regions, and acquisition sources.
How to interpret the traffic data
In the ChartX vs Weave monthly traffic comparison, ChartX currently shows 3.4K visits and Weave shows 1.3M; Weave has about 392.5 times the visible traffic of ChartX, an absolute difference of about 1.3M visits. This reflects visible reach, not feature quality or paid users.
Only Weave has complete third-party traffic details; ChartX uses visits recorded inside ToolMage. These scopes cannot estimate market share directly, and on-site views should not be treated as the product’s total website traffic.
ChartX monthly traffic:
Latest traffic
월 방문
3.4K
Weave monthly traffic:
Latest traffic
월 방문
1.3M
평균 방문 시간
5:37
방문당 페이지
5.95
이탈률
38.35%
Data updated 2026-06-15
Monthly traffic trend
- 2025/9: 878.5K 월 방문
- 2026/1: 1.1M 월 방문
- 2026/2: 1M 월 방문
- 2026/3: 1.1M 월 방문
- 2026/4: 1.2M 월 방문
- 2026/5: 1.3M 월 방문
주요 지역
Top 5 countries/regions
| Country/region | Percentage | Traffic |
|---|---|---|
| 🇺🇸United States | 97.08% | 1.3M |
| 🇨🇦Canada | 1.34% | 17.8K |
| 🇵🇭Philippines | 0.71% | 9.4K |
| 🇮🇳India | 0.6% | 8K |
| 🇬🇧United Kingdom | 0.27% | 3.6K |
트래픽 소스
| Source type | Percentage | Traffic |
|---|---|---|
| 직접 | 70.04% | 930.8K |
| 리퍼럴 | 24.58% | 326.6K |
| 이메일 | 5.38% | 71.5K |
검색 키워드
google reviewsweaveweave admin portalweave loginweave welcome back login
Traffic-based selection guidance: The current traffic scope is not sufficient for a reliable product ranking. Treat monthly visits as a market-interest signal, then decide using taxonomy, use cases, pricing, and a like-for-like trial rather than reading exposure as product capability.
Usage comparison
Compare the core capabilities of ChartX and Weave
ChartX Core features
실무 관리
운영
재무 관리
Weave Core features
실무 관리
CRM
통신
Use cases
ChartX Use cases
요양원 청구
노인 돌봄 관리
헬스케어 금융
HIPAA 준수
호스피스 소프트웨어
의료비 청구 자동화
환자 온보딩
수익 주기 관리
Weave Use cases
AI 비서
약속 예약
치과 소프트웨어
헬스케어 CRM
온라인 결제
환자 소통
실무 관리
평판 관리
문자 마케팅
VoIP
ChartX vs Weave：In-depth comparison and selection guidance
First decide whether the products solve the same kind of need
This in-depth ChartX vs Weave comparison uses only the product records, taxonomy, audience, traffic, and community signals available on this page. ChartX is primarily listed under “운영”, while Weave is primarily listed under “CRM”, so the first decision is whether your actual task matches their recorded scope.
The structured fields currently show these decision-relevant differences: Primary category (ChartX: 운영; Weave: CRM); Monthly visits (ChartX: 3.4K; Weave: 1.3M); Favorites (ChartX: 106; Weave: 120); Website (ChartX: www.chartx.ai; Weave: www.getweave.com); Added (ChartX: 2025-08-11; Weave: 2025-08-12). These facts are more useful for selection than brand visibility alone.
What market visibility and monthly traffic mean
In the ChartX vs Weave monthly traffic comparison, ChartX currently shows 3.4K visits and Weave shows 1.3M; Weave has about 392.5 times the visible traffic of ChartX, an absolute difference of about 1.3M visits. This reflects visible reach, not feature quality or paid users.
Only Weave has complete third-party traffic details; ChartX uses visits recorded inside ToolMage. These scopes cannot estimate market share directly, and on-site views should not be treated as the product’s total website traffic.
The current traffic scope is not sufficient for a reliable product ranking. Treat monthly visits as a market-interest signal, then decide using taxonomy, use cases, pricing, and a like-for-like trial rather than reading exposure as product capability.
Product positioning, use cases, and roles
ChartX and Weave currently overlap in shared categories: 실무 관리. This can place both on the same shortlist, but it does not prove equal implementation, depth, or cost.
ChartX's unique categories/tags are 운영, 재무 관리, 요양원 청구, 노인 돌봄 관리, 헬스케어 금융, HIPAA 준수, 호스피스 소프트웨어 및 의료비 청구 자동화; Weave's are CRM, 통신, AI 비서, 약속 예약, 치과 소프트웨어, 헬스케어 CRM, 온라인 결제 및 환자 소통. These unique fields are the strongest differentiators: validate the product whose recorded scope matches the task instead of following traffic alone.
What ratings, comments, and favorites can tell you
ChartX has no verified rating, 0 comments, 106 favorites, and 106 likes；Weave has no verified rating, 0 comments, 120 favorites, and 113 likes。
Neither product has enough rating or comment samples for a credible reputation ranking.
Selection guidance by actual need
When to evaluate ChartX first
Put ChartX on the priority trial list when the task aligns with “운영” and especially 운영, 재무 관리, 요양원 청구, 노인 돌봄 관리, 헬스케어 금융 및 HIPAA 준수. This follows recorded positioning and does not imply unlisted capabilities are absent.
ChartX also currently records: pricing is paid, product type is website, 3.4K on-site monthly views, no verified user rating. Verify any hard requirement around price, platform, or reach before trial, and do not let sparse review data substitute for testing.
When to evaluate Weave first
Put Weave on the priority trial list when the task aligns with “CRM” and especially CRM, 통신, AI 비서, 약속 예약, 치과 소프트웨어 및 헬스케어 CRM. This follows recorded positioning and does not imply unlisted capabilities are absent.
Weave also currently records: pricing is paid, product type is website, 1.3M verified monthly visits, no verified user rating. Verify any hard requirement around price, platform, or reach before trial, and do not let sparse review data substitute for testing.
How to validate the recommendation before deciding
The available data describes positioning, public visibility, and community signals, but it cannot prove output quality, speed, integration effort, privacy, or long-term cost in your workflow. Before deciding, run the same representative tasks in ChartX and Weave, then record completion time, accuracy, manual corrections, and the real paid threshold. A like-for-like trial turns this comparison into a defensible adoption decision.
비교 FAQ
How should I choose between ChartX and Weave?
Compare positioning, pricing, taxonomy, and traffic maturity, then verify the latest details on each official website.
Where does this comparison data come from?
The factual baseline is derived from product, taxonomy, traffic, and community data. Reviewed editorial conclusions show their source and verification date.
What do unknown fields mean?
Unknown means there is not enough reliable evidence; the page does not fill gaps with assumptions.